You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-vascular endothelial growth factor (Anti-VEGF)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

Recruiting
  • Macular Edema Due to Type 2 Diabetes Mellitus
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 26, 2023

Adult Diabetic Macular Edema and Suboptimal Response to

Not yet recruiting
  • Diabetic Macular Edema
    • (no location specified)
    Jul 31, 2023

    Following Intensive Anti-VEGF Therapy in Wet AMD

    Completed
    • Age-Related Macular Degeneration
    • Budapest, Hungary
    • +1 more
    Dec 28, 2022

    Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

    Recruiting
    • Retinal Vein Occlusion
    • Aflibercept Ophthalmic
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Jan 5, 2022

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Intravitreal Injection Site and Perceived Pain

    Recruiting
    • Pain
    • Intravitreal injection site
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 19, 2023

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Ocular Adverse Events in Neovascular Age-related Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

    Active, not recruiting
    • Recurrent Brain Neoplasm
    • Bevacizumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

    Recruiting
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Bevacizumab
    • +4 more
    • Phoenix, Arizona
    • +2 more
    Jun 27, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Completed
    Has Results
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +8 more
    • Bevacizumab
    • Irinotecan Sucrosofate
    • Chicago, Illinois
      Northwestern University
    Dec 21, 2022

    Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

    Not yet recruiting
    • Ovarian Clear Cell Adenocarcinoma
    • +14 more
    • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
    • +4 more
    • Buffalo, New York
    • +1 more
    Dec 16, 2022

    Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

    Recruiting
    • Resectable Hepatocellular Carcinoma
    • +4 more
    • Atezolizumab
    • +2 more
    • Houston, Texas
    • +1 more
    Oct 12, 2022

    Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

    Not yet recruiting
    • Fallopian Tube Carcinosarcoma
    • +10 more
    • Bevacizumab
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 29, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +5 more
    • Bevacizumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 13, 2022

    Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb

    Recruiting
    • Age Related Macular Degeneration
    • recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
    • Xuzhou, Jiangsu, China
      XuZhou Central Hospital
    Feb 7, 2022

    Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell

    Recruiting
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • +9 more
    • Duarte, California
    • +4 more
    Aug 17, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Bevacizumab
    • +2 more
    • Los Angeles, California
    • +17 more
    Jan 27, 2023

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

    Not yet recruiting
    • Metastatic Colon Adenocarcinoma
    • +6 more
    • Balstilimab
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Nov 17, 2022

    Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

    Not yet recruiting
    • Metastatic Colorectal Carcinoma
    • +3 more
    • Bevacizumab
    • +11 more
    • (no location specified)
    May 9, 2023

    Retinal Pigment Epithelium Detachment in Neovascular Age-related

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • Anti-vascular endothelial growth factor therapy
    • Krasnodar, Russian Federation
      The S.N. Fyodorov Eye Microsurgery State Institution
    Jan 12, 2022

    Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Columbus

    Recruiting
    • Metastatic Colorectal Carcinoma
    • +4 more
    • Bevacizumab
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 14, 2021

    Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Invasive Breast Carcinoma
    • Triple-Negative Breast Carcinoma
    • Bevacizumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 18, 2022

    Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

    Completed
    • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
    • Wenzhou, Zhejiang, China
      The First Affiliated Hospital of Wenzhou Medical University
    Nov 6, 2023

    Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

    Recruiting
    • Cervical Adenocarcinoma
    • +47 more
    • Bevacizumab
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Dec 5, 2022